Literature DB >> 16177824

Mediation of Epstein-Barr virus EBNA-LP transcriptional coactivation by Sp100.

Paul D Ling1, Rong Sheng Peng, Ayako Nakajima, Jiang H Yu, Jie Tan, Stephanie M Moses, Wei-Hong Yang, Bo Zhao, Elliott Kieff, Kenneth D Bloch, Donald B Bloch.   

Abstract

The Epstein-Barr virus (EBV) EBNA-LP protein is important for EBV-mediated B-cell immortalization and is a potent gene-specific coactivator of the viral transcriptional activator, EBNA2. The mechanism(s) by which EBNA-LP functions as a coactivator remains an important question in the biology of EBV-induced B-cell immortalization. In this study, we found that EBNA-LP interacts with the promyelocytic leukemia nuclear body (PML NB)-associated protein Sp100 and displaces Sp100 and heterochromatin protein 1alpha (HP1alpha) from PML NBs. Interaction between EBNA-LP and Sp100 was mediated through conserved region 3 in EBNA-LP and the PML NB targeting domain in Sp100. Overexpression of Sp100 lacking the N-terminal PML NB targeting domain, but not a mutant form of Sp100 lacking the HP1alpha interaction domain, was sufficient to coactivate EBNA2 in a gene-specific manner independent of EBNA-LP. These findings suggest that Sp100 is a major mediator of EBNA-LP coactivation. These studies indicate that modulation of PML NB-associated proteins may be important for establishment of latent viral infections, and also identify a convenient model system to investigate the functions of Sp100.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16177824      PMCID: PMC1276704          DOI: 10.1038/sj.emboj.7600820

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  65 in total

1.  The function of PML in p53-dependent apoptosis.

Authors:  A Guo; P Salomoni; J Luo; A Shih; S Zhong; W Gu; P P Pandolfi
Journal:  Nat Cell Biol       Date:  2000-10       Impact factor: 28.824

2.  Lytic but not latent replication of epstein-barr virus is associated with PML and induces sequential release of nuclear domain 10 proteins.

Authors:  P Bell; P M Lieberman; G G Maul
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

Review 3.  Molecular virology of Epstein-Barr virus.

Authors:  G W Bornkamm; W Hammerschmidt
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2001-04-29       Impact factor: 6.237

4.  Common properties of nuclear body protein SP100 and TIF1alpha chromatin factor: role of SUMO modification.

Authors:  J S Seeler; A Marchio; R Losson; J M Desterro; R T Hay; P Chambon; A Dejean
Journal:  Mol Cell Biol       Date:  2001-05       Impact factor: 4.272

5.  Epstein-barr virus immediate-early protein BZLF1 is SUMO-1 modified and disrupts promyelocytic leukemia bodies.

Authors:  A L Adamson; S Kenney
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

6.  EBNA-LP associates with cellular proteins including DNA-PK and HA95.

Authors:  I Han; S Harada; D Weaver; Y Xue; W Lane; S Orstavik; B Skalhegg; E Kieff
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

Review 7.  Biology and disease associations of Epstein-Barr virus.

Authors:  D H Crawford
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2001-04-29       Impact factor: 6.237

Review 8.  Oncogenes and tumor suppressors in the molecular pathogenesis of acute promyelocytic leukemia.

Authors:  P P Pandolfi
Journal:  Hum Mol Genet       Date:  2001-04       Impact factor: 6.150

9.  Evidence for separate ND10-binding and homo-oligomerization domains of Sp100.

Authors:  D Negorev; A M Ishov; G G Maul
Journal:  J Cell Sci       Date:  2001-01       Impact factor: 5.285

10.  PML is critical for ND10 formation and recruits the PML-interacting protein daxx to this nuclear structure when modified by SUMO-1.

Authors:  A M Ishov; A G Sotnikov; D Negorev; O V Vladimirova; N Neff; T Kamitani; E T Yeh; J F Strauss; G G Maul
Journal:  J Cell Biol       Date:  1999-10-18       Impact factor: 10.539

View more
  44 in total

1.  EBV nuclear antigen EBNALP dismisses transcription repressors NCoR and RBPJ from enhancers and EBNA2 increases NCoR-deficient RBPJ DNA binding.

Authors:  Daniel Portal; Bo Zhao; Michael A Calderwood; Thomas Sommermann; Eric Johannsen; Elliott Kieff
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-25       Impact factor: 11.205

2.  Epstein-Barr virus and virus human protein interaction maps.

Authors:  Michael A Calderwood; Kavitha Venkatesan; Li Xing; Michael R Chase; Alexei Vazquez; Amy M Holthaus; Alexandra E Ewence; Ning Li; Tomoko Hirozane-Kishikawa; David E Hill; Marc Vidal; Elliott Kieff; Eric Johannsen
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-19       Impact factor: 11.205

3.  Hsp72 up-regulates Epstein-Barr virus EBNALP coactivation with EBNA2.

Authors:  Chih-Wen Peng; Bo Zhao; Hong-Chi Chen; Min-Luen Chou; Chiou-Yan Lai; Shinn-Zong Lin; Hsue-Yin Hsu; Elliott Kieff
Journal:  Blood       Date:  2007-03-06       Impact factor: 22.113

4.  Human cytomegalovirus infection causes degradation of Sp100 proteins that suppress viral gene expression.

Authors:  Young-Eui Kim; Jin-Hyoung Lee; Eui Tae Kim; Hye Jin Shin; Su Yeon Gu; Hyang Sook Seol; Paul D Ling; Chan Hee Lee; Jin-Hyun Ahn
Journal:  J Virol       Date:  2011-08-31       Impact factor: 5.103

5.  Regulation of Epstein-Barr virus latency type by the chromatin boundary factor CTCF.

Authors:  Charles M Chau; Xiao-Yong Zhang; Steven B McMahon; Paul M Lieberman
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

6.  Murine gammaherpesvirus 68 ORF75c contains ubiquitin E3 ligase activity and requires PML SUMOylation but not other known cellular PML regulators, CK2 and E6AP, to mediate PML degradation.

Authors:  Jaturong Sewatanon; Paul D Ling
Journal:  Virology       Date:  2013-03-27       Impact factor: 3.616

7.  Sp100A is a tumor suppressor that activates p53-dependent transcription and counteracts E1A/E1B-55K-mediated transformation.

Authors:  J Berscheminski; J Brun; T Speiseder; P Wimmer; W H Ip; M Terzic; T Dobner; S Schreiner
Journal:  Oncogene       Date:  2015-10-19       Impact factor: 9.867

8.  Sp100 isoform-specific regulation of human adenovirus 5 gene expression.

Authors:  Julia Berscheminski; Peter Wimmer; Juliane Brun; Wing Hang Ip; Peter Groitl; Tim Horlacher; Ellis Jaffray; Ron T Hay; Thomas Dobner; Sabrina Schreiner
Journal:  J Virol       Date:  2014-03-12       Impact factor: 5.103

9.  Extensive co-operation between the Epstein-Barr virus EBNA3 proteins in the manipulation of host gene expression and epigenetic chromatin modification.

Authors:  Robert E White; Ian J Groves; Ernest Turro; Jade Yee; Elisabeth Kremmer; Martin J Allday
Journal:  PLoS One       Date:  2010-11-15       Impact factor: 3.240

10.  Truncated form of the Epstein-Barr virus protein EBNA-LP protects against caspase-dependent apoptosis by inhibiting protein phosphatase 2A.

Authors:  Julie Garibal; Emilie Hollville; Andrew I Bell; Gemma L Kelly; Benjamin Renouf; Yasushi Kawaguchi; Alan B Rickinson; Joëlle Wiels
Journal:  J Virol       Date:  2007-05-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.